Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Immunopharmacology|March 17, 2024
Elevated expression of LCN13 through FXR activation ameliorates hepatocellular lipid accumulation and inflammationXingliang Qin, Yongyao Tan, Weishu Ren, et al.
Environmental Toxicology|September 6, 2021
Long-term ketamine administration induces bladder damage and upregulates autophagy-associated proteins in bladder smooth muscle tissueYanning Li, Zhibin Dong, Gehua Wen, et al.
Toxicology|April 4, 2022
Ketamine promotes the amyloidogenic pathway by regulating endosomal pHWeishu Ren, Haoyang Lou, Xinghua Ren, et al.
Biomarker Research|November 14, 2024
Exosomal PSM-E inhibits macrophage M2 polarization to suppress prostate cancer metastasis through the RACK1 signaling axisXingliang Qin, Ruoxi Niu, Yongyao Tan, et al.
Cell Death & Disease|June 25, 2024
Dexmedetomidine improves the circulatory dysfunction of the glymphatic system induced by sevoflurane through the PI3K/AKT/ΔFosB/AQP4 pathway in young miceShuying Wang, Xiaojin Yu, Lili Cheng, et al.
International Immunopharmacology|March 2, 2025
C19orf66 restricts Coxsackievirus B infection by inducing lysosomal degradation of the viral proteins 3Dpol and 2Apro and exhibits neuroprotective effects in CVB-challenged miceYongyao Tan, Weishu Ren, Weiwei Zhou, et al.
Frontiers in Psychiatry|May 23, 2019
Regulation of Tau Protein on the Antidepressant Effects of Ketamine in the Chronic Unpredictable Mild Stress ModelGehua Wen, Hui Yao, Yanning Li, et al.
Molecular Neurobiology|October 15, 2023
Ketamine Improves the Glymphatic Pathway by Reducing the Pyroptosis of Hippocampal Astrocytes in the Chronic Unpredictable Mild Stress ModelGehua Wen, Xiaoni Zhan, Xiaoming Xu, et al.
Frontiers in Behavioral Neuroscience|May 5, 2020
Redistribution of Monocarboxylate 1 and 4 in Hippocampus and Spatial Memory Impairment Induced by Long-term Ketamine AdministrationRuntao Ding, Yaqing Tan, Ao Du, et al.
Pageof 1